… We thank Cédric Laouénan for help with the statistical analysis; Alexandra Athanasiou,
Caroline Malhaire, and Liliane Ollivier for review of imaging; Bénédicte Lebrun-Vignes and Raoul …

Background Dupilumab is the first biologic available to treat atopic dermatitis (AD). Its
effectiveness and safety were demonstrated in clinical trials. Objective We sought to assess the …

Objective. Ischemic digital ulcers (DU) are frequent and severe complications of systemic
sclerosis (SSc). The purpose of our study was to assess the effect of DU on hand disability and …

Background. The objective was to assess the response rate and survival of patients with
metastatic mucosal melanoma (MM) and uveal melanoma (UM) treated with anti-CTLA-4 or anti-…

Simple Summary Prognosis of advanced cutaneous squamous-cell carcinoma (CSCC) is
poor. Recent clinical trials have shown that immunotherapy achieves significantly improved …

Background Occupational exposure is reported as playing a substantial causative role in
systemic sclerosis (SSc). Objective We sought to compare the characteristics of SSc in patients …

Importance Evidence for the long-term efficacy and safety of anti–tumor necrosis factor α
agents (anti-TNF) in treating cutaneous sarcoidosis is lacking. Objective To determine the …

There is no standard of care for unresectable cutaneous squamous cell carcinoma (cSCC).
Chemotherapy, alone or combined with radiotherapy, is commonly used mostly as palliative …

Background Genital psoriasis is often under‐recognized. Objectives To assess the instantaneous
prevalence of genital psoriasis and describe its clinical features, association with a …

Although the combination of rituximab and polychemotherapy has improved prognosis of
primary cutaneous diffuse large B-cell lymphoma, leg type, the advanced age of patients limits …